Cite
HARVARD Citation
Escobar, M. et al. (2022). A phase IV, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures. Haemophilia. 28 (4), pp. e105-e108. [Online].